iBio Inc [IBIO] stock is trading at $2.7, saw in change for the day. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The IBIO shares have gain 43.62% over the last week, with a monthly amount drifted -3.91%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
iBio Inc [NASDAQ: IBIO] stock has seen the most recent analyst activity on October 21, 2025, when Oppenheimer initiated its Outperform rating and assigned the stock a price target of $5. Previously, Leerink Partners started tracking the stock with Outperform rating on October 17, 2025, and set its price target to $2. On May 28, 2024, Chardan Capital Markets initiated with a Buy rating and assigned a price target of $5 on the stock. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $1.50 on November 29, 2021. Cantor Fitzgerald initiated its recommendation with an Overweight and recommended $3 as its price target on January 22, 2021. Alliance Global Partners started tracking with a Buy rating for this stock on June 26, 2020, and assigned it a price target of $2.55.
iBio Inc [IBIO] stock has fluctuated between $0.56 and $6.89 over the past year. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. iBio Inc [NASDAQ: IBIO] shares were valued at $2.7 at the most recent close of the market. An investor can expect a potential drop of -25.93% based on the average IBIO price forecast.
Analyzing the IBIO fundamentals
Gross Profit Margin for this corporation currently stands at 0.42% with Operating Profit Margin at -40.89%, Pretax Profit Margin comes in at -40.22%, and Net Profit Margin reading is -40.22%. To continue investigating profitability, this company’s Return on Assets is posted at -0.31, Equity is -0.84 and Total Capital is -0.35. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
For context, iBio Inc’s Current Ratio is 8.39. As well, the Quick Ratio is 8.39, while the Cash Ratio is 4.65. Considering the valuation of this stock, the price to sales ratio is 121.44, the price to book ratio is 0.98.
